1 Introduction to Research & Analysis Reports
    1.1 Anti-Hypertensive Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Anti-Hypertensive Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Anti-Hypertensive Drugs Overall Market Size
    2.1 Global Anti-Hypertensive Drugs Market Size: 2021 VS 2028
    2.2 Global Anti-Hypertensive Drugs Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Anti-Hypertensive Drugs Sales: 2017-2028
3 Company Landscape
    3.1 Top Anti-Hypertensive Drugs Players in Global Market
    3.2 Top Global Anti-Hypertensive Drugs Companies Ranked by Revenue
    3.3 Global Anti-Hypertensive Drugs Revenue by Companies
    3.4 Global Anti-Hypertensive Drugs Sales by Companies
    3.5 Global Anti-Hypertensive Drugs Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Anti-Hypertensive Drugs Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Anti-Hypertensive Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Anti-Hypertensive Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Anti-Hypertensive Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Anti-Hypertensive Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Anti-Hypertensive Drugs Market Size Markets, 2021 & 2028
        4.1.2 Diuretics
        4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors
        4.1.4 Angiotensin Receptor Blockers (ARBs)
        4.1.5 Calcium Channel Blockers
        4.1.6 Beta Blockers
        4.1.7 Alpha Blockers
        4.1.8 Vasodilators
        4.1.9 Renin Inhibitors
    4.2 By Type - Global Anti-Hypertensive Drugs Revenue & Forecasts
        4.2.1 By Type - Global Anti-Hypertensive Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Anti-Hypertensive Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    4.3 By Type - Global Anti-Hypertensive Drugs Sales & Forecasts
        4.3.1 By Type - Global Anti-Hypertensive Drugs Sales, 2017-2022
        4.3.2 By Type - Global Anti-Hypertensive Drugs Sales, 2023-2028
        4.3.3 By Type - Global Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    4.4 By Type - Global Anti-Hypertensive Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Anti-Hypertensive Drugs Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Anti-Hypertensive Drugs Revenue & Forecasts
        5.2.1 By Application - Global Anti-Hypertensive Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Anti-Hypertensive Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    5.3 By Application - Global Anti-Hypertensive Drugs Sales & Forecasts
        5.3.1 By Application - Global Anti-Hypertensive Drugs Sales, 2017-2022
        5.3.2 By Application - Global Anti-Hypertensive Drugs Sales, 2023-2028
        5.3.3 By Application - Global Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    5.4 By Application - Global Anti-Hypertensive Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Anti-Hypertensive Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Anti-Hypertensive Drugs Revenue & Forecasts
        6.2.1 By Region - Global Anti-Hypertensive Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Anti-Hypertensive Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    6.3 By Region - Global Anti-Hypertensive Drugs Sales & Forecasts
        6.3.1 By Region - Global Anti-Hypertensive Drugs Sales, 2017-2022
        6.3.2 By Region - Global Anti-Hypertensive Drugs Sales, 2023-2028
        6.3.3 By Region - Global Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Anti-Hypertensive Drugs Revenue, 2017-2028
        6.4.2 By Country - North America Anti-Hypertensive Drugs Sales, 2017-2028
        6.4.3 US Anti-Hypertensive Drugs Market Size, 2017-2028
        6.4.4 Canada Anti-Hypertensive Drugs Market Size, 2017-2028
        6.4.5 Mexico Anti-Hypertensive Drugs Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Anti-Hypertensive Drugs Revenue, 2017-2028
        6.5.2 By Country - Europe Anti-Hypertensive Drugs Sales, 2017-2028
        6.5.3 Germany Anti-Hypertensive Drugs Market Size, 2017-2028
        6.5.4 France Anti-Hypertensive Drugs Market Size, 2017-2028
        6.5.5 U.K. Anti-Hypertensive Drugs Market Size, 2017-2028
        6.5.6 Italy Anti-Hypertensive Drugs Market Size, 2017-2028
        6.5.7 Russia Anti-Hypertensive Drugs Market Size, 2017-2028
        6.5.8 Nordic Countries Anti-Hypertensive Drugs Market Size, 2017-2028
        6.5.9 Benelux Anti-Hypertensive Drugs Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Anti-Hypertensive Drugs Revenue, 2017-2028
        6.6.2 By Region - Asia Anti-Hypertensive Drugs Sales, 2017-2028
        6.6.3 China Anti-Hypertensive Drugs Market Size, 2017-2028
        6.6.4 Japan Anti-Hypertensive Drugs Market Size, 2017-2028
        6.6.5 South Korea Anti-Hypertensive Drugs Market Size, 2017-2028
        6.6.6 Southeast Asia Anti-Hypertensive Drugs Market Size, 2017-2028
        6.6.7 India Anti-Hypertensive Drugs Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Anti-Hypertensive Drugs Revenue, 2017-2028
        6.7.2 By Country - South America Anti-Hypertensive Drugs Sales, 2017-2028
        6.7.3 Brazil Anti-Hypertensive Drugs Market Size, 2017-2028
        6.7.4 Argentina Anti-Hypertensive Drugs Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Anti-Hypertensive Drugs Sales, 2017-2028
        6.8.3 Turkey Anti-Hypertensive Drugs Market Size, 2017-2028
        6.8.4 Israel Anti-Hypertensive Drugs Market Size, 2017-2028
        6.8.5 Saudi Arabia Anti-Hypertensive Drugs Market Size, 2017-2028
        6.8.6 UAE Anti-Hypertensive Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Novartis
        7.1.1 Novartis Corporate Summary
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Anti-Hypertensive Drugs Major Product Offerings
        7.1.4 Novartis Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.1.5 Novartis Key News
    7.2 Pfizer
        7.2.1 Pfizer Corporate Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Anti-Hypertensive Drugs Major Product Offerings
        7.2.4 Pfizer Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.2.5 Pfizer Key News
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporate Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Anti-Hypertensive Drugs Major Product Offerings
        7.3.4 Johnson & Johnson Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.3.5 Johnson & Johnson Key News
    7.4 Sanofi
        7.4.1 Sanofi Corporate Summary
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi Anti-Hypertensive Drugs Major Product Offerings
        7.4.4 Sanofi Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.4.5 Sanofi Key News
    7.5 Lupin
        7.5.1 Lupin Corporate Summary
        7.5.2 Lupin Business Overview
        7.5.3 Lupin Anti-Hypertensive Drugs Major Product Offerings
        7.5.4 Lupin Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.5.5 Lupin Key News
    7.6 Ranbaxy Laboratories
        7.6.1 Ranbaxy Laboratories Corporate Summary
        7.6.2 Ranbaxy Laboratories Business Overview
        7.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Major Product Offerings
        7.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.6.5 Ranbaxy Laboratories Key News
    7.7 Merck
        7.7.1 Merck Corporate Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Anti-Hypertensive Drugs Major Product Offerings
        7.7.4 Merck Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.7.5 Merck Key News
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporate Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Anti-Hypertensive Drugs Major Product Offerings
        7.8.4 AstraZeneca Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.8.5 AstraZeneca Key News
    7.9 Daiichi Sankyo Company Limited
        7.9.1 Daiichi Sankyo Company Limited Corporate Summary
        7.9.2 Daiichi Sankyo Company Limited Business Overview
        7.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Major Product Offerings
        7.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.9.5 Daiichi Sankyo Company Limited Key News
    7.10 Takeda Pharmaceutical
        7.10.1 Takeda Pharmaceutical Corporate Summary
        7.10.2 Takeda Pharmaceutical Business Overview
        7.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Major Product Offerings
        7.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales and Revenue in Global (2017-2022)
        7.10.5 Takeda Pharmaceutical Key News
8 Global Anti-Hypertensive Drugs Production Capacity, Analysis
    8.1 Global Anti-Hypertensive Drugs Production Capacity, 2017-2028
    8.2 Anti-Hypertensive Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Anti-Hypertensive Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Anti-Hypertensive Drugs Supply Chain Analysis
    10.1 Anti-Hypertensive Drugs Industry Value Chain
    10.2 Anti-Hypertensive Drugs Upstream Market
    10.3 Anti-Hypertensive Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Anti-Hypertensive Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Anti-Hypertensive Drugs in Global Market
    Table 2. Top Anti-Hypertensive Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Anti-Hypertensive Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Anti-Hypertensive Drugs Revenue Share by Companies, 2017-2022
    Table 5. Global Anti-Hypertensive Drugs Sales by Companies, (K Units), 2017-2022
    Table 6. Global Anti-Hypertensive Drugs Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Anti-Hypertensive Drugs Price (2017-2022) & (USD/Pcs)
    Table 8. Global Manufacturers Anti-Hypertensive Drugs Product Type
    Table 9. List of Global Tier 1 Anti-Hypertensive Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Anti-Hypertensive Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type ? Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Anti-Hypertensive Drugs Sales (K Units), 2017-2022
    Table 15. By Type - Global Anti-Hypertensive Drugs Sales (K Units), 2023-2028
    Table 16. By Application ? Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Anti-Hypertensive Drugs Sales (K Units), 2017-2022
    Table 20. By Application - Global Anti-Hypertensive Drugs Sales (K Units), 2023-2028
    Table 21. By Region ? Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Anti-Hypertensive Drugs Sales (K Units), 2017-2022
    Table 25. By Region - Global Anti-Hypertensive Drugs Sales (K Units), 2023-2028
    Table 26. By Country - North America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Anti-Hypertensive Drugs Sales, (K Units), 2017-2022
    Table 29. By Country - North America Anti-Hypertensive Drugs Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Anti-Hypertensive Drugs Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Anti-Hypertensive Drugs Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Anti-Hypertensive Drugs Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Anti-Hypertensive Drugs Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Anti-Hypertensive Drugs Sales, (K Units), 2023-2028
    Table 38. By Country - South America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Anti-Hypertensive Drugs Sales, (K Units), 2017-2022
    Table 41. By Country - South America Anti-Hypertensive Drugs Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Anti-Hypertensive Drugs Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Anti-Hypertensive Drugs Sales, (K Units), 2023-2028
    Table 46. Novartis Corporate Summary
    Table 47. Novartis Anti-Hypertensive Drugs Product Offerings
    Table 48. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 49. Pfizer Corporate Summary
    Table 50. Pfizer Anti-Hypertensive Drugs Product Offerings
    Table 51. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 52. Johnson & Johnson Corporate Summary
    Table 53. Johnson & Johnson Anti-Hypertensive Drugs Product Offerings
    Table 54. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 55. Sanofi Corporate Summary
    Table 56. Sanofi Anti-Hypertensive Drugs Product Offerings
    Table 57. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 58. Lupin Corporate Summary
    Table 59. Lupin Anti-Hypertensive Drugs Product Offerings
    Table 60. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 61. Ranbaxy Laboratories Corporate Summary
    Table 62. Ranbaxy Laboratories Anti-Hypertensive Drugs Product Offerings
    Table 63. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 64. Merck Corporate Summary
    Table 65. Merck Anti-Hypertensive Drugs Product Offerings
    Table 66. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 67. AstraZeneca Corporate Summary
    Table 68. AstraZeneca Anti-Hypertensive Drugs Product Offerings
    Table 69. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 70. Daiichi Sankyo Company Limited Corporate Summary
    Table 71. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product Offerings
    Table 72. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 73. Takeda Pharmaceutical Corporate Summary
    Table 74. Takeda Pharmaceutical Anti-Hypertensive Drugs Product Offerings
    Table 75. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 76. Anti-Hypertensive Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 77. Global Anti-Hypertensive Drugs Capacity Market Share of Key Manufacturers, 2020-2022
    Table 78. Global Anti-Hypertensive Drugs Production by Region, 2017-2022 (K Units)
    Table 79. Global Anti-Hypertensive Drugs Production by Region, 2023-2028 (K Units)
    Table 80. Anti-Hypertensive Drugs Market Opportunities & Trends in Global Market
    Table 81. Anti-Hypertensive Drugs Market Drivers in Global Market
    Table 82. Anti-Hypertensive Drugs Market Restraints in Global Market
    Table 83. Anti-Hypertensive Drugs Raw Materials
    Table 84. Anti-Hypertensive Drugs Raw Materials Suppliers in Global Market
    Table 85. Typical Anti-Hypertensive Drugs Downstream
    Table 86. Anti-Hypertensive Drugs Downstream Clients in Global Market
    Table 87. Anti-Hypertensive Drugs Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Anti-Hypertensive Drugs Segment by Type
    Figure 2. Anti-Hypertensive Drugs Segment by Application
    Figure 3. Global Anti-Hypertensive Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Anti-Hypertensive Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Anti-Hypertensive Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. Anti-Hypertensive Drugs Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Anti-Hypertensive Drugs Revenue in 2021
    Figure 9. By Type - Global Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 10. By Type - Global Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Anti-Hypertensive Drugs Price (USD/Pcs), 2017-2028
    Figure 12. By Application - Global Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 13. By Application - Global Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Anti-Hypertensive Drugs Price (USD/Pcs), 2017-2028
    Figure 15. By Region - Global Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 16. By Region - Global Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 19. US Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 24. Germany Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. France Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 33. China Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. India Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 40. Brazil Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Anti-Hypertensive Drugs Sales Market Share, 2017-2028
    Figure 44. Turkey Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Anti-Hypertensive Drugs Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Anti-Hypertensive Drugs Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Anti-Hypertensive Drugs by Region, 2021 VS 2028
    Figure 50. Anti-Hypertensive Drugs Industry Value Chain
    Figure 51. Marketing Channels

This report contains market size and forecasts of Anti-Hypertensive Drugs in global, including the following market information:
Global Anti-Hypertensive Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-Hypertensive Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-Hypertensive Drugs companies in 2021 (%)
The global Anti-Hypertensive Drugs market was valued at 40890 million in 2021 and is projected to reach US$ 48250 million by 2028, at a CAGR of 2.4% during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Diuretics Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Hypertensive Drugs include Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, AstraZeneca and Daiichi Sankyo Company Limited and  etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Hypertensive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Hypertensive Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, by Type, 2021 (%)
    Diuretics
    Angiotensin Converting Enzyme (ACE) Inhibitors
    Angiotensin Receptor Blockers (ARBs)
    Calcium Channel Blockers
    Beta Blockers
    Alpha Blockers
    Vasodilators
    Renin Inhibitors
Global Anti-Hypertensive Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, by Application, 2021 (%)
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
Global Anti-Hypertensive Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Hypertensive Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-Hypertensive Drugs revenues share in global market, 2021 (%)
Key companies Anti-Hypertensive Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-Hypertensive Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Novartis
    Pfizer
    Johnson & Johnson
    Sanofi
    Lupin
    Ranbaxy Laboratories
    Merck
    AstraZeneca
    Daiichi Sankyo Company Limited
    Takeda Pharmaceutical